Your browser doesn't support javascript.
loading
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs.
De Stefano, Ludovico; Balduzzi, Silvia; Bogliolo, Laura; D'Onofrio, Bernardo; di Lernia, Michele; Mauric, Eleonora; Milanesi, Alessandra; Brandolino, Fabio; Rocca, Clarissa; Chiricolo, Sofia; Manzo, Antonio; Montecucco, Carlomaurizio; Bugatti, Serena.
Afiliação
  • De Stefano L; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Balduzzi S; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
  • Bogliolo L; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
  • D'Onofrio B; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • di Lernia M; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Mauric E; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Milanesi A; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Brandolino F; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Rocca C; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Chiricolo S; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Manzo A; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Montecucco C; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
  • Bugatti S; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, and Department of Internal Medicine and Therapeutics, University of Pavia, Italy. serena.bugatti@unipv.it.
Clin Exp Rheumatol ; 41(3): 667-675, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36135948
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2023 Tipo de documento: Article